1. Home
  2. LSPD vs REPL Comparison

LSPD vs REPL Comparison

Compare LSPD & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightspeed Commerce Inc. Subordinate Voting Shares

LSPD

Lightspeed Commerce Inc. Subordinate Voting Shares

HOLD

Current Price

$10.94

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$11.73

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSPD
REPL
Founded
2005
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
LSPD
REPL
Price
$10.94
$11.73
Analyst Decision
Hold
Buy
Analyst Count
18
8
Target Price
$10.85
★ $19.50
AVG Volume (30 Days)
805.4K
★ 1.8M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.93
N/A
Revenue Next Year
$12.42
$497.81
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.83
$1.50
52 Week High
$13.72
$16.33

Technical Indicators

Market Signals
Indicator
LSPD
REPL
Relative Strength Index (RSI) 60.40 41.64
Support Level $10.81 $6.81
Resistance Level $11.80 $12.50
Average True Range (ATR) 0.36 0.68
MACD 0.10 -0.14
Stochastic Oscillator 83.23 34.48

Price Performance

Historical Comparison
LSPD
REPL

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc is a one-stop commerce platform providing its customers with the critical functionalities needed to engage with consumers, manage their operations, order their inventory, accept payments, and run their business. It has customers globally in over 100 countries, empowering single- and multi-location small and medium-sized businesses to compete in an omni-channel market environment by engaging with consumers across online, mobile, social, and physical channels. Its products are divided into retail, restaurant, and golf categories. Geographically, it operates in Canada, the United States, the United Kingdom, Switzerland, Germany, and Others with the majority of revenue deriving from Canada.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

Share on Social Networks: